Lifetime costs and life-years gained associated with apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation
May 1, 2013, 00:00
10.1016/j.jval.2013.03.1483
https://www.valueinhealthjournal.com/article/S1098-3015(13)01554-4/fulltext
Title :
Lifetime costs and life-years gained associated with apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01554-4&doi=10.1016/j.jval.2013.03.1483
First page :
A286
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
1053